Corrections 2 Flashcards

1
Q

What does cryoprecipitate contain?

A

Factor VIII
Fibrinogen
vWf
Factor XIII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the major constituent of cryoprecipitate?

A

Factor VIII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is CML blast transformation?

A

The final stage of CML

CML transforms until an acute leukaemia, usually AML.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Features of blast transformation in CML?

A
  • fever
  • fatigue
  • SOB
  • enlarged spleen
  • bone pain
  • abdo pain
  • night sweats
  • weight loss
  • bleeding
  • infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the universal donor of FFP?

A

AB RhD negative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mechanism of dabigatran?

A

Direct thrombin inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What investigation should be used to diagnose hereditary spherocytosis?

A

EMA binding test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

1st line imaging in suspected multiple myeloma?

A

Whole body MRI - to assess for bony involvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the treatment of choice in TTP?

A

Plasma exchange

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Features of TTP?

A
  • fever
  • fluctuating neuro signs (microemboli)
  • renal failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Blood test results in TTP?

A

1) Microangiopathic haemolytic anaemia –> schistocytes

2) Thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are schistocytes on a peripheral blood smear a characteristic feature of?

A

Microangiopathic hemolytic anemia:

  • DIC
  • TTP
  • HUS
  • HELLP
  • malfunctioning cardiac valves
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Causes of TTP?

A
  • post-infection e.g. GI, urinary
  • pregnancy
  • SLE
  • HIV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Metabolic abnormalities in tumour lysis syndrome?

A
  • high potassium
  • high phosphate
  • low calcium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the platelet threshold for transfusion for patients with severe bleeding, or bleeding at critical sites, such as the CNS?

A

<100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Platelet transfusion thresholds:

1) patients with clinically significant bleeding e.g. haematemesis, melaena, prolonged epistaxis

2) patients with severe bleeding or CNS bleeding

A

1) <30
2) <100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What platelet level should you aim for prior to surgery/invasive procedure?

A

> 50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How should TXA be given in cases of major haemorrhage?

A

IV bolus followed by slow infusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the most common hereditary haemolytic anaemia in people of northern European descent? (e.g. Finland)

A

Hereditary spherocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is erythema infectiosum caused by?

A

Parvovirus (‘slapped cheek’)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Mx of post-thrombotic syndrome?

A

Graudated compression stockings

22
Q

Features of post-thrombotic syndrome?

A
  • painful, heavy calves
  • pruritus
  • swelling
  • varicose veins
  • venous ulceration
23
Q

What is required to diagnose tumour lysis syndrome?

A

Laboratory tumour lysis syndrome plus one or more of the following:

1) increase in serum creatinine (1.5x upper limit of normal)

2) cardiac arrhythmia or sudden death

3) seizure

24
Q

A peripherlal blood smear showing spherocytes can be found in what 2 conditions?

A

1) hereditary spherocytosis

2) autoimmune haemolytic anaemia

25
Q

Pathophysiology of haemophilia?

A

Interferes with the intrinsic pathway of the coagulation cascade.

Factor VIII/IX deficiency –> reduced activation of factor X to Xa –> reduced generation of thrombin –> reduced conversion of fibrinogen (soluble) to insoluble fibrin (provides structural integrity of a clot).

26
Q

Which clotting pathway is affected in haemophilia?

A

Intrinsic coagulation cascade

27
Q

What clotting study result is one of the hallmarks of haemophilia?

A

Prolonged APTT (this represents a delay in the intrinsic coagulation pathway).

28
Q

How can clotting studies differentiate between vitamin K deficiency or DIC and haemophillia?

A

Haemophilia:
- prolonged APTT (intrinsic)
- normal PT

Vitamin K deficiency:
- prolonged PT
- can have a prolonged APTT

29
Q

What is the most sensitive screening test to detect early or mild vitamin K deficiency?

A

Prolonged PT

30
Q

Mx of haemophilia?

A

Replacement of clotting factors: VIII in haemophilia A, IX in haemophilia B

31
Q

What can be used in acute episodes of mild haemophilia A to promote the function of vWf?

A

Desmopressin

32
Q

Inheritance of thalassaemia?

A

Autosomal recessive

33
Q

Cause of beta-thalassaemia?

A

Mutation in globin (HBB) gene on chromosome 11

34
Q

HbA vs HbA2 levels in beta-thalassaemia major?

A

HbA: absent

HbA2: raised (HbF is also raised)

35
Q

What is required for a diagnosis of polycythaemia vera?

A

1) Mutation in JAK2

and

2) High haematocrit (>0.52 in men, >0.48 in women) OR raised red cell mass (>25% above predicted)

36
Q

What is used to reduce risk of thrombosis in polycythaemia vera?

37
Q

1st line mx of polycythaemia vera?

A

Venesection

38
Q

What is the mainstay of imaging for staging HL?

A

PET/CT

This combines functional imaging from PET, which detects areas of increased metabolic activity, with anatomical imaging from CT, providing precise localisation of disease sites.

39
Q

What is the initial investigation of choice in suspected polycythaemia vera?

A

JAK2 mutation screen - this is +ve in approx 95% of PV cases

40
Q

Mechanism of:

a) rivaroxaban
b) apixaban
c) dabigatran
d) heparin

A

a) direct factor Xa inhibitor
b) direct factor Xa inhibitor
c) direct thrombin inhibitor
d) activates antithrombin III

41
Q

What clotting factors does warfarin inhibit?

A

II, VII, IX and X

42
Q

What is the most likely biochem findings in myeloma (without mets)?

A
  • raised calcium
  • normal phosphate
  • normal ALP
43
Q

Is extra-nodal disease more common in HL or non-HL?

44
Q

What medication is often used in the mx of non-HL?

45
Q

What should all patients be screened for prior to receiving treatment with rituximab?

A

Hep B (can cause reactivation)

46
Q

Why does SLE commonly cause neutropenia?

A

Autoimmune destruction of neutrophils

47
Q

What is the single most important factor in determining whether cryoprecipitate should be given?

A

A low fibrinogen level

48
Q

What is cryoprecipitate mainly used in the mx of?

A

DIC –> indicated for the treatment of hypofibrinogenaemia

49
Q

What blood product may be indicated in:

a) prolonged APTT
b) prolonged PT
c) low fibrinogen

A

a) FPP
b) FPP
c) cryoprecipitate